Nobutaka Ikeda1, Hisao Hara2, Yukio Hiroi2, Masato Nakamura3. 1. Division of Cardiovascular Medicine, National Center for Global Health and Medicine, Japan; Division of Cardiovascular Medicine, Toho University Ohashi Medical Center, Japan. Electronic address: ikedanobutaka@yahoo.co.jp. 2. Division of Cardiovascular Medicine, National Center for Global Health and Medicine, Japan. 3. Division of Cardiovascular Medicine, Toho University Ohashi Medical Center, Japan.
Abstract
BACKGROUND AND AIMS: Increasing evidence has demonstrated that postprandial hyperglycemia and fluctuation of glucose level affect cardiovascular events. The serum 1,5-anhydro-d-glucitol (1,5-AG) level rapidly decreases concomitantly with urinary glucose excretion in hyperglycemia and is a useful clinical marker of short-term glycemic status. However, there is few established evidence regarding the predictive value of 1,5-AG for cardiovascular events in individuals without diabetes mellitus (DM). The aim of this study is 1) to prove predictive value of 1,5-AG for cardiovascular events in high risk population, and 2) the predictive value is true of even in non-diabetic population. METHODS: Serum 1,5-AG values and coronary angiograms of 889 patients were evaluated. The study patients were divided into two groups (1,5-AG<10.0 μg/ml-group and 1,5-AG≥10.0 μg/ml-group) by their measured 1,5-AG values. They were followed-up and information regarding major adverse cardiac and cerebrovascular events (MACCE) was collected. MACCE consists of all causes of death, stroke, non-fatal myocardial infarction and cardiovascular hospitalization. RESULTS: During the follow-up period (757 ± 357days), 216 patients presented with MACCE. In all patients, the 1,5-AG <10.0 μg/ml -group demonstrated significantly higher risk of MACCE (adjusted hazard ratio 1.63). Even in non-DM patients without coronary artery disease, the 1,5-AG <10.0 μg/m-group showed significantly higher risk of MACCE (adjusted hazard ratio 2.34). Similar results were found even if the events were limited to: all cause death, non-fatal myocardial infarction and stroke (adjusted hazard ratio 4.07) or all cause death (adjusted hazard ratio 3.54). CONCLUSIONS: Serum 1,5-AG value predicts MACCE even in non-DM patients without coronary artery disease.
BACKGROUND AND AIMS: Increasing evidence has demonstrated that postprandial hyperglycemia and fluctuation of glucose level affect cardiovascular events. The serum 1,5-anhydro-d-glucitol (1,5-AG) level rapidly decreases concomitantly with urinary glucose excretion in hyperglycemia and is a useful clinical marker of short-term glycemic status. However, there is few established evidence regarding the predictive value of 1,5-AG for cardiovascular events in individuals without diabetes mellitus (DM). The aim of this study is 1) to prove predictive value of 1,5-AG for cardiovascular events in high risk population, and 2) the predictive value is true of even in non-diabetic population. METHODS: Serum 1,5-AG values and coronary angiograms of 889 patients were evaluated. The study patients were divided into two groups (1,5-AG<10.0 μg/ml-group and 1,5-AG≥10.0 μg/ml-group) by their measured 1,5-AG values. They were followed-up and information regarding major adverse cardiac and cerebrovascular events (MACCE) was collected. MACCE consists of all causes of death, stroke, non-fatal myocardial infarction and cardiovascular hospitalization. RESULTS: During the follow-up period (757 ± 357days), 216 patients presented with MACCE. In all patients, the 1,5-AG <10.0 μg/ml -group demonstrated significantly higher risk of MACCE (adjusted hazard ratio 1.63). Even in non-DMpatients without coronary artery disease, the 1,5-AG <10.0 μg/m-group showed significantly higher risk of MACCE (adjusted hazard ratio 2.34). Similar results were found even if the events were limited to: all cause death, non-fatal myocardial infarction and stroke (adjusted hazard ratio 4.07) or all cause death (adjusted hazard ratio 3.54). CONCLUSIONS: Serum 1,5-AG value predicts MACCE even in non-DMpatients without coronary artery disease.
Authors: Mary R Rooney; Dan Wang; J William McEvoy; Stephen P Juraschek; John Chalmers; Mark Woodward; Elizabeth Selvin Journal: Diabetes Res Clin Pract Date: 2021-11-17 Impact factor: 5.602
Authors: Man Li; Nisa M Maruthur; Stephanie J Loomis; Maik Pietzner; Kari E North; Hao Mei; Alanna C Morrison; Nele Friedrich; James S Pankow; Matthias Nauck; Eric Boerwinkle; Alexander Teumer; Elizabeth Selvin; Anna Köttgen Journal: Sci Rep Date: 2017-06-06 Impact factor: 4.379
Authors: Stephanie J Loomis; Anna Köttgen; Man Li; Adrienne Tin; Josef Coresh; Eric Boerwinkle; Richard Gibbs; Donna Muzny; James Pankow; Elizabeth Selvin; Priya Duggal Journal: Sci Rep Date: 2019-04-11 Impact factor: 4.379
Authors: Kristina Pigsborg; Gözde Gürdeniz; Oscar Daniel Rangel-Huerta; Kirsten B Holven; Lars Ove Dragsted; Stine M Ulven Journal: Eur J Nutr Date: 2022-01-09 Impact factor: 4.865